RealClearHealth Week of September 9, 2019 Archives

RealClearHealth AM Update

Tuesday, September 10

Pelosi Aims to Negotiate Medicare Prices

Yasmeen Abutaleb Washington Post

House Drug Price Plan Could Apply Beyond Medicare

Andrew Siddons Roll Call

Impact of Senate Rx Pricing Bill

Scott Gottlieb Benedic N. Ippolito & Abigail Keller AEI Ideas

States Pass Record Number of Laws on Rx Drugs

Steven Findlay Kaiser Health News

Our Unstable Abortion Regime

Alexandra DeSanctis National Review

On Abortion, Dems Are Living in Fantasy Land

John Daniel Davidson The Federalist

Patent Trolls Are Not Useful

Mytheos Holt Townhall

Americans Hate Big Pharma

Allana Akhtar Business Insider

Wednesday, September 11

Bipartisan Group Tells FDA to go Beyond E-Cig Flavor Ban

Andrew Siddons Roll Call

The Stakes of the Vape Debate

The Editors Wall Street Journal

The Good, Bad, & Ugly: Pelosi's Rx Pricing Proposal

Christopher Jacobs The Federalist

For Drug Companies, Real Costs to Unpopularity

Charley Grant Wall Street Journal

Trump Reforms and the New Insurance Numbers

Brian Blase National Review

9/11 Anniversary: Honoring First Responders

Greg Norman FOX News

18 Years On: 9/11 Illnesses Devastating First Responders

Niall McCarthy Forbes

How States Are Lowering Obamacare Premiums

Doug Badger The Daily Signal

Health Care Tax Cut for Seniors

Ryan Ellis Washington Examiner

New House Drug Pricing Bill Is a Joke

Peter Pitts DrugWonks

Drug Importation: High Risk, Low Reward

Liam Sigaud RealClearHealth

How the Left Gets it Wrong on Health Spending

Robert E. Moffit Heritage Foundation

Drug Prices Top DC's Agenda

Stephanie Armour & Andrew Duehren Wall Street Journal

Burned Out

Marschall S. Runge RealClearHealth

Monday, September 16

FDA on Vaping

Editorial Board Washington Post

Vaping Ban Will Mean Back to the Pack

Liam Sigaud & Steve Pociask Wall Street Journal

Purdue Pharma Files for Bankruptcy

Jan Hoffman & Mary Williams Walsh New York Times

Amidst Dem Debate, Pelosi Unveils Controversial Drug Plan

Doug Schoen Forbes

Biden Praised Pharma at a Private Party

Ellen Cranley Business Insider